2/25
04:14 pm
rhhby
Nykode Therapeutics AS (VACBF) Q4 2025 Earnings Call Highlights: Navigating Financial ... [Yahoo! Finance]
Low
Report
Nykode Therapeutics AS (VACBF) Q4 2025 Earnings Call Highlights: Navigating Financial ... [Yahoo! Finance]
2/25
01:39 pm
rhhby
Roche Holding (SWX:ROG) Valuation Check After Key FDA And Phase III Milestones [Yahoo! Finance]
Low
Report
Roche Holding (SWX:ROG) Valuation Check After Key FDA And Phase III Milestones [Yahoo! Finance]
2/25
08:23 am
rhhby
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer [Yahoo! Finance]
Low
Report
Parker Institute for Cancer Immunotherapy Announces Appointment of Bob Purcell as Chief Communications Officer [Yahoo! Finance]
2/25
07:13 am
rhhby
BreezeBio banks $60M to make more precise genetic medicines [Yahoo! Finance]
Low
Report
BreezeBio banks $60M to make more precise genetic medicines [Yahoo! Finance]
2/23
05:00 pm
rhhby
Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions
Low
Report
Flatiron Health Attends the 2026 American Society of Genitourinary Cancers Symposium to Answer Oncology's Most Critical Questions
2/20
02:00 am
rhhby
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
Low
Report
FDA Approves Genentech’s Venclexta® Plus Acalabrutinib Combination Regimen for Previously Untreated Chronic Lymphocytic Leukemia
2/20
01:35 am
rhhby
FDA Accepts New Drug Application for Genentech's Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer [Yahoo! Finance]
Low
Report
FDA Accepts New Drug Application for Genentech's Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer [Yahoo! Finance]
2/20
01:25 am
rhhby
FDA accepts New Drug Application for Roche's giredestrant in ESR1-mutated, ER-positive advanced breast cancer [Yahoo! Finance]
Low
Report
FDA accepts New Drug Application for Roche's giredestrant in ESR1-mutated, ER-positive advanced breast cancer [Yahoo! Finance]
2/20
01:05 am
rhhby
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
Low
Report
FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
2/18
09:00 am
rhhby
Flatiron Launches First-of-Its-Kind AI-Powered Global Prostate Cancer Datasets
Low
Report
Flatiron Launches First-of-Its-Kind AI-Powered Global Prostate Cancer Datasets
2/16
07:51 am
rhhby
Roche eyes Gazyva label expansion on positive Phase III kidney disease data [Yahoo! Finance]
Low
Report
Roche eyes Gazyva label expansion on positive Phase III kidney disease data [Yahoo! Finance]
2/16
01:00 am
rhhby
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
Low
Report
Genentech Announces Positive Phase III Results for Gazyva in Primary Membranous Nephropathy, Marking a Significant Milestone in This Autoimmune Disease
2/11
09:00 am
rhhby
Flatiron Health Names New Chief Business, Technology, and Product Leaders
Low
Report
Flatiron Health Names New Chief Business, Technology, and Product Leaders
2/10
10:14 am
rhhby
Roche (OTCMKTS:RHHBY) had its "hold" rating reaffirmed by analysts at TD Cowen.
Low
Report
Roche (OTCMKTS:RHHBY) had its "hold" rating reaffirmed by analysts at TD Cowen.
2/10
03:36 am
rhhby
Roche Holding (SWX:ROG) Valuation Check After Recent Share Price Momentum And Conflicting Fair Value Views [Yahoo! Finance]
Low
Report
Roche Holding (SWX:ROG) Valuation Check After Recent Share Price Momentum And Conflicting Fair Value Views [Yahoo! Finance]
2/7
04:37 pm
rhhby
Genentech's Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) [Yahoo! Finance]
Low
Report
Genentech's Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS) [Yahoo! Finance]
2/7
03:40 pm
rhhby
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
Low
Report
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
2/4
02:04 pm
rhhby
Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Roche (OTCMKTS:RHHBY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
2/4
08:00 am
rhhby
Genentech Awards Grant to Support Science Center's Translation Project
Low
Report
Genentech Awards Grant to Support Science Center's Translation Project
2/3
06:46 am
rhhby
SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal [Yahoo! Finance]
Low
Report
SanegeneBio and Genentech sign $1.5bn global RNAi licensing deal [Yahoo! Finance]
2/3
04:13 am
rhhby
Pharmaceutical Contract Development and Manufacturing Organization Forecasts Report 2026: A $374.68 Billion Market by 2031 - One-Stop CDMOs, Rapid AI Platforms, and GLP-1/HPAPI Build-Outs Drive Demand [Yahoo! Finance]
Low
Report
Pharmaceutical Contract Development and Manufacturing Organization Forecasts Report 2026: A $374.68 Billion Market by 2031 - One-Stop CDMOs, Rapid AI Platforms, and GLP-1/HPAPI Build-Outs Drive Demand [Yahoo! Finance]
2/2
04:19 pm
rhhby
Genentech in up to $1.7B RNAi licensing deal with SanegeneBio [Seeking Alpha]
Low
Report
Genentech in up to $1.7B RNAi licensing deal with SanegeneBio [Seeking Alpha]
2/2
03:33 pm
rhhby
North Carolina is State of the Year, business magazine says [Yahoo! Finance]
Low
Report
North Carolina is State of the Year, business magazine says [Yahoo! Finance]
2/2
10:19 am
rhhby
ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging [Yahoo! Finance]
Low
Report
ACROBiosystems Powers Innovation at bioSeedin's JPM Spotlight, Strategically Supporting Global Partnership Forging [Yahoo! Finance]
2/2
07:29 am
rhhby
SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech [Yahoo! Finance]
Low
Report
SanegeneBio Announces RNAi Global Licensing Collaboration with Genentech [Yahoo! Finance]